Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4516 AL 4530

Parkinson's disease and cardiovascular disease: A complex combination of clinical conundrums

Wimmer NJ.

Trends Cardiovasc Med. 2026 Jan 27:S1050-1738(26)00010-1. doi: 10.1016/j.tcm.2026.01.004. Online ahead of print.

The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease

Teil M, Huot P.

Curr Opin Neurobiol. 2026 Apr;97:103164. doi: 10.1016/j.conb.2025.103164. Epub 2026 Jan 21.

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial

Fernandez HH, Isaacson SH, Hauser RA, Agarwal P, Ondo W, Park A, Kremens D, Leoni M, Duvvuri S, Combs C, Koenig E, Chang I, Pastino G, Tringali S, Golonski N, Sanchez R, Harmer L, Boiser J, Zadikoff C, Mari Z.

JAMA Neurol. 2026 May 1;83(5):442-451. doi: 10.1001/jamaneurol.2026.0577.

Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial

Pahwa R, Moro E, Espay AJ, Evans A, Saint-Hilaire M, Torres-Russotto D, Sanchez R, Leoni M, Duvvuri S, Combs C, Chang I, Tringali S, Boiser J, Zadikoff C, Antonini A.

JAMA Neurol. 2026 May 1;83(5):452-460. doi: 10.1001/jamaneurol.2026.0590.

LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial

Mabrouk OS, Tichler B, Arnold HM, Thoma EC, Alexanian SM, Chen J, Liu TY, Hirschhorn B, Llorens Arenas R, Annand JW, Kapadnis U, Shomo AA, Glajch KE, Ferber K, Moroishi Y, Czerkowicz J, Inra J, Postuma RB, Gurevich T, Mir P, Morris HR, Aldred J, Brodsky MA, Ellenbogen A, Larson D, Tolleson CM, Siderowf A, Tzoulis C, Balaguer E, Marti MJ, Zhao HT, Kordasiewicz HB, Lane R, Hirst WD, Fradette S, Graham DL.

Nat Med. 2026 Apr;32(4):1421-1431. doi: 10.1038/s41591-026-04262-4. Epub 2026 Mar 24.

Future Directions: The Parkinson's Precision Medicine Initiative

Marek K, Tropea TF.

Ann Neurol. 2026 Oct;100 Suppl 38:S118-S119. doi: 10.1002/ana.78244. Epub 2026 May 6.

Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational study

Stocchi F, Barone P, Ceravolo R, De Pandis MF, Lopiano L, Modugno N, Padovani A, Pilleri M, Tessitore A, Zappia M.

Ann Med. 2026 Dec;58(1):2628353. doi: 10.1080/07853890.2026.2628353. Epub 2026 Mar 4.

Parkinson's and Alzheimer's disease impairs temporal precision

Weber MA, Hunter CM, Narayanan NS.

Res Sq [Preprint]. 2026 Jan 20:rs.3.rs-8628264. doi: 10.21203/rs.3.rs-8628264/v1.

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative

Weintraub D, Dobkin RD, York MK, Chahine LM, Tropea TF, Marek K; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S47-S52. doi: 10.1002/ana.78254. Epub 2026 May 13.

Editorial: Technology developments and clinical applications of artificial intelligence in neurodegenerative diseases

Li C, Li C.

Front Neurol. 2026 Feb 24;17:1802039. doi: 10.3389/fneur.2026.1802039. eCollection 2026.

Editorial: Neuroprotective and therapeutic effects of progesterone, allopregnanolone, and their derivatives

Guennoun R, Sayeed I, Stein D.

Front Endocrinol (Lausanne). 2026 Jan 15;17:1771389. doi: 10.3389/fendo.2026.1771389. eCollection 2026.

Editorial: Genetic underpinnings of Alzheimer's and Parkinson's: insights and innovations

Marongiu R, Cordato D, Reiss AB.

Front Genet. 2026 Apr 21;17:1846361. doi: 10.3389/fgene.2026.1846361. eCollection 2026.

From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI

Marek K, Chowdhury S, Tropea TF; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S10-S16. doi: 10.1002/ana.78242. Epub 2026 May 5.

Editorial: Methods in motor neuroscience

Salido-Ruiz RA.

Front Hum Neurosci. 2026 Feb 3;20:1788976. doi: 10.3389/fnhum.2026.1788976. eCollection 2026.

Foslevodopa-foscarbidopa infusion

Street D, Teare L, Lindahl A, Martin H, Bateman B, Strens L, Samra AP.

Pract Neurol. 2026 May 14;26(3):229-236. doi: 10.1136/pn-2025-004777.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias